aspirin and 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide

aspirin has been researched along with 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grosser, N; Schröder, H2

Other Studies

2 other study(ies) available for aspirin and 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide

ArticleYear
A common pathway for nitric oxide release from NO-aspirin and glyceryl trinitrate.
    Biochemical and biophysical research communications, 2000, Jul-21, Volume: 274, Issue:1

    Topics: Animals; Aspirin; Cell Line; Cyclic GMP; Cyclic N-Oxides; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Epithelial Cells; Free Radical Scavengers; Imidazoles; Kidney; Molsidomine; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Protein Binding; Swine

2000
Aspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathway.
    Arteriosclerosis, thrombosis, and vascular biology, 2003, Aug-01, Volume: 23, Issue:8

    Topics: Animals; Aspirin; Cattle; Cell Survival; Cells, Cultured; Citrulline; Cyclic GMP; Cyclic N-Oxides; Cytoprotection; Diclofenac; Endothelium, Vascular; Enzyme Inhibitors; Guanylate Cyclase; Hydrogen Peroxide; Imidazoles; Indomethacin; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Swine

2003